PNC FINANCIAL SERVICES GROUP, INC.

Position in PTGX — Protagonist Therapeutics, Inc

CIK 713676 Pittsburgh, PA

Position in PTGX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$546,457

+$125,069 QoQ

Shares Held

4,458

+11.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#208

of 343 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 97% Shared 2% None 1%

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. PTGX ranks #32 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	69,358	$34,452,195
2	REGN	Regeneron Pharmaceuticals, Inc.	16,662	$10,389,420
3	TECH	BIO-TECHNE Corp	77,074	$5,445,277
4	MRNA	Moderna, Inc.	70,829	$4,960,151
5	TGTX	Tg Therapeutics, Inc.	89,646	$4,925,149
6	DNTH	Dianthus Therapeutics, Inc. /DE/	39,473	$3,847,827
7	INCY	Incyte Corp	32,777	$3,715,597
8	ARGX	Argenx SE	3,967	$3,680,460

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$546,457	4,458	+11.5%	Shares	Defined	2026-08-07
2026-03-31	$421,388	3,998	+35.1%	Shares	Defined	2026-05-08
2025-12-31	$258,436	2,959	+8.1%	Shares	Defined	2026-02-06
2025-09-30	$181,882	2,738	+13.4%	Shares	Defined	2025-11-07
2025-06-30	$133,420	2,414	+21.2%	Shares	Defined	2025-08-08
2025-03-31	$96,332	1,992	+38.2%	Shares	Defined	2025-05-09
2024-12-31	$55,620	1,441	-16.7%	Shares	Defined	2025-02-07
2024-09-30	$77,805	1,729	+12250.0%	Shares	Defined	2024-11-08
2024-06-30	$485	14	+180.0%	Shares	Defined	2024-08-09
2023-12-31	$114	5	-95.7%	Shares	Defined	2024-03-22
2023-09-30	$1,918	115	0.0%	Shares	Defined	2023-11-13
2023-06-30	$3,176	115	0.0%	Shares	Defined	2023-08-11
2023-03-31	$2,645	115	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.